June E. Ayling

1.8k total citations
51 papers, 1.4k citations indexed

About

June E. Ayling is a scholar working on Molecular Biology, Clinical Biochemistry and Biochemistry. According to data from OpenAlex, June E. Ayling has authored 51 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 22 papers in Clinical Biochemistry and 13 papers in Biochemistry. Recurrent topics in June E. Ayling's work include Metabolism and Genetic Disorders (22 papers), Biochemical and Molecular Research (10 papers) and Folate and B Vitamins Research (10 papers). June E. Ayling is often cited by papers focused on Metabolism and Genetic Disorders (22 papers), Biochemical and Molecular Research (10 papers) and Folate and B Vitamins Research (10 papers). June E. Ayling collaborates with scholars based in United States, Switzerland and France. June E. Ayling's co-authors include Steven Bailey, Esmond E. Snell, Wolfgang Pirson, Igor Rebrin, É. Kun, Günther Boehm, Harmon C. Dunathan, Beat Thöny, Feodor Lynen and Charles M. Baugh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

June E. Ayling

50 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
June E. Ayling United States 24 665 394 363 207 175 51 1.4k
Edwin G. Moore United States 16 460 0.7× 119 0.3× 292 0.8× 144 0.7× 344 2.0× 22 1.3k
F. Van Hoof Belgium 18 621 0.9× 325 0.8× 358 1.0× 91 0.4× 503 2.9× 43 1.4k
John I. Toohey United States 19 1.0k 1.5× 101 0.3× 448 1.2× 556 2.7× 98 0.6× 33 1.8k
Bryan E. Hainline United States 17 851 1.3× 565 1.4× 111 0.3× 113 0.5× 204 1.2× 29 1.5k
Laishram Rajendrakumar Singh India 19 464 0.7× 136 0.3× 298 0.8× 107 0.5× 158 0.9× 41 960
S.K. Wadman Netherlands 32 2.1k 3.1× 1.7k 4.3× 284 0.8× 479 2.3× 483 2.8× 136 3.3k
Dan A. Richert United States 23 645 1.0× 202 0.5× 68 0.2× 186 0.9× 230 1.3× 56 1.4k
Dominique Padovani France 19 884 1.3× 159 0.4× 608 1.7× 849 4.1× 138 0.8× 30 1.7k
Gian Franco Gaetani Italy 19 789 1.2× 122 0.3× 60 0.2× 96 0.5× 335 1.9× 45 1.9k
Grażyna Chwatko Poland 22 483 0.7× 235 0.6× 639 1.8× 744 3.6× 104 0.6× 69 1.9k

Countries citing papers authored by June E. Ayling

Since Specialization
Citations

This map shows the geographic impact of June E. Ayling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by June E. Ayling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites June E. Ayling more than expected).

Fields of papers citing papers by June E. Ayling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by June E. Ayling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by June E. Ayling. The network helps show where June E. Ayling may publish in the future.

Co-authorship network of co-authors of June E. Ayling

This figure shows the co-authorship network connecting the top 25 collaborators of June E. Ayling. A scholar is included among the top collaborators of June E. Ayling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with June E. Ayling. June E. Ayling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Staines, Anthony, Cecily Kelleher, Leslie Daly, et al.. (2012). Unmetabolized folic acid prevalence is widespread in the older Irish population despite the lack of a mandatory fortification program. American Journal of Clinical Nutrition. 96(3). 613–621. 28 indexed citations
3.
4.
Bailey, Steven & June E. Ayling. (2009). The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Proceedings of the National Academy of Sciences. 106(36). 15424–15429. 303 indexed citations
5.
Sweeney, Mary Rose, Anthony Staines, Leslie Daly, et al.. (2009). Persistent circulating unmetabolised folic acid in a setting of liberal voluntary folic acid fortification. Implications for further mandatory fortification?. BMC Public Health. 9(1). 295–295. 49 indexed citations
6.
Hevel, Joan M., et al.. (2008). Determinants of oligomerization of the bifunctional protein DCoHα and the effect on its enzymatic and transcriptional coactivator activities. Archives of Biochemistry and Biophysics. 477(2). 356–362. 3 indexed citations
8.
Hevel, Joan M., Jason A. Stewart, Katherine L. Gross, & June E. Ayling. (2006). Can the DCoHα isozyme compensate in patients with 4a-hydroxy-tetrahydrobiopterin dehydratase/DCoH deficiency?. Molecular Genetics and Metabolism. 88(1). 38–46. 11 indexed citations
9.
Ayling, June E., Steven Bailey, Roberto Giugliani, et al.. (2000). Hyperphenylalaninemia and 7-Pterin Excretion Associated with Mutations in 4a-Hydroxy-tetrahydrobiopterin Dehydratase/DCoH: Analysis of Enzyme Activity in Intestinal Biopsies. Molecular Genetics and Metabolism. 70(3). 179–188. 6 indexed citations
10.
Thöny, Beat, L. Kierat, M. Blaskovics, et al.. (1998). Hyperphenylalaninemia with High Levels of 7-Biopterin is Associated with Mutations in the PCBD Gene Encoding the Bifunctional Protein Pterin-4a-Carbinolamine Dehydratase and Transcriptional Coactivator (DCoH). The American Journal of Human Genetics. 62(6). 1302–1311. 40 indexed citations
11.
Thöny, Beat, L. Kierat, Marie-Odile Rolland, et al.. (1998). Mutations in the pterin-4α-carbinolamine dehydratase ( PCBD ) gene cause a benign form of hyperphenylalaninemia. Human Genetics. 103(2). 162–167. 30 indexed citations
12.
Bailey, Steven & June E. Ayling. (1997). Total chemical synthesis of chirally pure (6S)-tetrahydrofolic acid. Methods in enzymology on CD-ROM/Methods in enzymology. 281. 3–16.
13.
Rebrin, Igor, Steven Bailey, & June E. Ayling. (1995). Activity of the Bifunctional Protein 4a-Hydroxy-Tetrahydropterin Dehydratase/DCoH during Human Fetal Development: Correlation with Dihydropteridine Reductase Activity and Tetrahydrobiopterin Levels. Biochemical and Biophysical Research Communications. 217(3). 958–965. 8 indexed citations
14.
Rebrin, Igor, et al.. (1995). Catalytic characterization of 4a-hydroxytetrahydropterin dehydratase. Biochemistry. 34(17). 5801–5810. 30 indexed citations
15.
Bailey, Steven, et al.. (1993). The Mechanism of Cofactor Regeneration During Phenylalanine Hydroxylation. Advances in experimental medicine and biology. 338. 47–54. 18 indexed citations
16.
Bailey, Steven, et al.. (1991). Role of C6 chirality of tetrahydropterin cofactor in catalysis and regulation of tyrosine and phenylalanine hydroxylases. Biochemistry. 30(42). 10226–10235. 11 indexed citations
18.
19.
Ayling, June E. & Ernest Kun. (1965). Studies with specific enzyme inhibitors. X. Mechanism of action of L-(+)-beta-monofluorlactate on crystalline heart muscle lactate dehydrogenase.. PubMed. 1(3). 255–65. 7 indexed citations
20.
Ayling, June E. & Ernest Kun. (1965). Studies with Specific Enzyme Inhibitors. Molecular Pharmacology. 1(3). 255–265. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026